MIREILLE SAINT JUSTE: Open Payments
NPI 1093149403 · UNION, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 29 payments from 10 companies in 2025. Trend: 2023 $633 · 2024 $349 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 7 | $312 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $99 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| SCILEX PHARMACEUTICALS INC. | 3 | $48 |
| Actelion Pharmaceuticals US, Inc. | 2 | $35 |
| Novo Nordisk Inc | 2 | $33 |
| ABBVIE INC. | 2 | $32 |
| EVOKE PHARMA, INC. | 1 | $25 |
| Verona Pharma, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
Products named: NUCALA, XIFAXAN, TRELEGY ELLIPTA, OPSUMIT, ZTLido, FASENRA, CREON, GIMOTI.
Industry payments across NJ — which companies pay providers there.
